title: At which stage of chronic kidney disease should dyslipidemia be treated?
authors.affiliation: Department of Medicine, Division of Nephrology, University Hospital of Würzburg, Josef-Schneider-Strasse 2, D-97080 Würzburg, Germany.
authors.forename: Vera
authors.initials: V
authors.lastname: Krane
authors.forename: Christoph
authors.initials: C
authors.lastname: Wanner
mesh_terms: D002318:Cardiovascular Diseases / Q000453:epidemiology*; D002908:Chronic Disease; D015897:Comorbidity; D050171:Dyslipidemias / Q000188:drug therapy* / Q000453:epidemiology*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D007674:Kidney Diseases / Q000453:epidemiology* / Q000628:therapy; D016030:Kidney Transplantation; D006435:Renal Dialysis
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors